Your Article Summary
MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants
Medimmune, 06/30/09
MedImmune continues to advance its commitment to pediatric research with announcement of the first observational prospective study designed to assess the burden of respiratory syncytial virus among preterm infants 32-to-35 weeks gestational age in outpatient settings during their first year of life.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility
Novartis, 11/25/09
Bayer CropScience signs Agreement with GVK Biosciences on early-stage research projects
BayNews International, 11/25/09
Reports Rate Ambulatory EHR Software
HealthDataManagement, 11/25/09
Article Search
Sponsor


See Latest Articles


